Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

Table 4 Comparison of baseline parameters of patients succumbing to various complications to those surviving at the end of the study (12 mo)

Parameter	Patients succumbing to complications (n = 17)	Surviving patients (n = 51)	P value
Age (yr)	44.53 ± 11.19	47.82 ± 10.07	0.26
Male:female	17:0	50:1	-
Ascites	17	47	0.23
Encephalopathy	8	35	0.19
Maddrey DF score	63.22 ± 18.58	53.61 ± 15.39	0.038
MELD score	23 ± 4.15	22.86 ± 3.50	0.89
GAHS	8.35 ± 0.99	8 ± 1.02	0.21
Child’s score	12 ± 1.06	12 ± 1.57	1.00
Mean TLC (/cm3)	14008.82 ± 2804.14	14764.71 ± 9827.88	0.77
Serum Na (mEq/L)	131.76 ± 4.51	134.80 ± 8.35	0.16
Serum K (mEq/L)	4.22 ± 1.12	4.25 ± 0.76	0.90
Urea (mg/dL)	31.94 ± 27.95	27.63 ± 21.22	0.51
Creatinine (mg/dL)	1.19 ± 0.32	1.33 ± 0.55	0.34
Bilirubin (mg/dL)	6.88 ± 4.92	5.71 ± 2.56	0.21
Albumin (gm/dL)	2.97 ± 0.74	3.16 ± 0.70	0.32
ALT (IU/L)	52 ± 20.66	57.51 ± 22.18	0.37
INR	2.14 ± 0.32	1.96 ± 0.31	0.049

All values are expressed as mean ± SD. P < 0.05 considered statistically significant.